Mpox primer for clinicians: what makes the difference in 2024?

By sjmartinez • January 16, 2025

Abdel-Rahman SM, Bayıcı BZ, Keske Ş, Kuşkucu M, Özsürekçi Y, Rimoin AW, Rodriguez-Morales AJ, Ergönül Ö. Mpox primer for clinicians: what makes the difference in 2024? Curr Opin Infect Dis. 2025 Jan 16. doi: 10.1097/QCO.0000000000001091. Epub ahead of print. PMID: 39813011.

Tags: Infectious Diseases, Publications

Rapid and comprehensive detection of viral antibodies and nucleic acids via an acoustofluidic integrated molecular diagnostics chip: AIMDx

Qian J, Xia J, Chiang S, Liu JF, Li K, Li F, Wei F, Aziz M, Kim Y, Go V, Morizio J, Zhong R, He[...]

Host-microbe multiomic profiling identifies distinct COVID-19 immune dysregulation in solid organ transplant recipients

Pickering H, Schaenman J, Phan HV, Maguire C, Tsitsiklis A, Rouphael N, Higuita NIA, Atkinson MA, Brakenridge S, Fung M, Messer W; IMPACC Network; Salehi-Rad[...]

MicroRNA Biomarkers and Host Response Pathways in Severe Pulmonary Hemorrhagic Syndrome due to Leptospirosis: A Multi-Omics Study

Tran PNT, Limothai U, Dinhuzen J, Tachaboon S, Sukmark T, Dokpong C, Roytrakul S, Haake DA, Srisawat N. MicroRNA Biomarkers and Host Response Pathways in[...]